Physician profile
George E Quill
NPI 1134110794
$304,130.41
in general payments reported to CMS, 2019-2025
15 companies · $33K in 2025
The $33K reported for 2025 was more than what 94% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $34K · 2021: $53K · 2022: $48K · 2023: $40K · 2024: $37K · 2025: $33K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $106K · Consulting Fee: $3,850 · Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $105,658.59 |
| Consulting Fee | $3,850.00 |
| Food and Beverage | $403.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $247,151.69 | 2019-2025 | Phoenix |
| Applied Medical Technology INC | $39,390.70 | 2019-2025 | Amt Bridle |
| Arthrex, INC. | $11,360.77 | 2019-2020 | |
| Auxano Medical LLC | $4,000.51 | 2025 | Intreped, Intraosseous Fusion Device |
| Alpha Orthopedic Systems | $941.89 | 2019-2020 | |
| Stryker Corporation | $527.66 | 2019-2022 | |
| Restor3d, INC. | $277.72 | 2023 | |
| Cumberland Pharmaceuticals, INC. | $120.22 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $115.58 | 2021 | |
| Bone Support INC. | $78.72 | 2022 | |
| Treace Medical Concepts, INC. | $60.00 | 2022 | |
| Ethicon US, LLC | $44.31 | 2019 | |
| Innovation Technologies INC | $33.67 | 2020 | |
| Medartis INC. | $21.60 | 2019 | |
| Crossroads Extremity Systems, LLC | $5.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Quill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.